Ultralife Corporation
ULBI
$4.13
-$0.15-3.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 12.79% | -91.31% | 2.70% | 1.72% | 113.68% |
| Total Depreciation and Amortization | 18.61% | -2.17% | 4.96% | 0.21% | -2.13% |
| Total Amortization of Deferred Charges | 291.67% | -25.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 170.65% | -90.08% | 12.50% | 390.48% | -63.56% |
| Change in Net Operating Assets | -62.24% | -15.19% | 183.62% | -206.41% | 57.64% |
| Cash from Operations | -35.82% | -46.82% | 11,118.52% | -103.33% | 373.57% |
| Capital Expenditure | -2.02% | -65.00% | 3.23% | 62.99% | -88.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -8,086.53% | -65.00% | 3.23% | 62.99% | -88.20% |
| Total Debt Issued | -- | -- | -- | -- | -48.72% |
| Total Debt Repaid | -99.23% | 69.40% | -2,535.80% | 66.67% | -200.00% |
| Issuance of Common Stock | 62.50% | -98.08% | 82.63% | 230.92% | -78.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,847.06% | -- | -- | -- | -- |
| Cash from Financing | 1,220.43% | 65.82% | -6,547.57% | 161.46% | -112.39% |
| Foreign Exchange rate Adjustments | -300.00% | 119.57% | -151.69% | 159.73% | -1,341.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.76% | 102.46% | -1,804.47% | -118.32% | -4.03% |